Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
Colorectal Cancer Screening Decision Support Tool in the Primary Care Bundle Questionnaire
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Suzanne Suzanne Brodney
- Phone Number: 6176434266
- Email: sbrodney@mgh.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Mass General Brigham
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Adults aged 45-75 overdue for CRC screening at average risk of CRC have an annual visit scheduled with participating practices
Exclusion Criteria:
- high risk of CRC
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: CRC decision tool
intervention arm
|
CRC decision tool included in the primary care bundle questionnaire
Other Names:
|
|
No Intervention: control
control arm
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CRC screening completion
Time Frame: 6 months
|
Assessment of electronic health record data to determine completion of CRC screening by any modality
|
6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Provider Experience
Time Frame: During the 6 month intervention phase
|
Provider-reported question: Did you feel the CRC screening tool informed or affected your conversations in any way?
|
During the 6 month intervention phase
|
|
Shared Decision Making Process Measure
Time Frame: During the 6 month intervention phase
|
Patient-reported survey question about involvement in the decision making process.
|
During the 6 month intervention phase
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Karen Sepucha, PhD, MGH
- Principal Investigator: Karen Blumenthal, MD, Massachusetts General Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2024P000687
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.